WHO emergency use authorisation to Bharat Biotech’s Covaxin delayed till October 5
Image Credit: Shortpedia
WHO approval for the emergency use authorisation (EUA) to Bharat Biotech’s COVID-19 vaccine Covaxin is likely to be delayed till October 5. According to WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin. A member of SAGE, Hanna Nohynek is going to introduce session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.